{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:29:53Z","timestamp":1770751793266,"version":"3.50.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,8,13]],"date-time":"2011-08-13T00:00:00Z","timestamp":1313193600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s00345-011-0736-6","type":"journal-article","created":{"date-parts":[[2011,8,12]],"date-time":"2011-08-12T08:53:30Z","timestamp":1313139210000},"page":"367-373","source":"Crossref","is-referenced-by-count":12,"title":["Videourodynamic changes of botulinum toxin A in patients with neurogenic bladder dysfunction (NBD) and idiopathic detrusor overactivity (IDO) refractory to drug treatment"],"prefix":"10.1007","volume":"30","author":[{"given":"S. H.","family":"Alloussi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ch.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Eichel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Al-Kaabneh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Seibold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Schwentner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Alloussi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,8,13]]},"reference":[{"issue":"1","key":"736_CR1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0090-4295(02)02243-4","volume":"61","author":"P Abrams","year":"2003","unstructured":"Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, Van Kerrebroeck P, Victor A, Wein A (2003) The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 61(1):37\u201349. doi: S0090429502022434","journal-title":"Urology"},{"issue":"9","key":"736_CR2","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1046\/j.1464-410x.2001.02228.x","volume":"87","author":"I Milsom","year":"2001","unstructured":"Milsom I, Abrams P, Cardozo L, Roberts RG, Thuroff J, Wein AJ (2001) How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 87(9):760\u2013766","journal-title":"BJU Int"},{"issue":"6","key":"736_CR3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00345-002-0301-4","volume":"20","author":"WF Stewart","year":"2003","unstructured":"Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, Hunt TL, Wein AJ (2003) Prevalence and burden of overactive bladder in the US. World J Urol 20(6):327\u2013336. doi: 10.1007\/s00345-002-0301-4","journal-title":"World J Urol"},{"issue":"7394","key":"736_CR4","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/bmj.326.7394.841","volume":"326","author":"P Herbison","year":"2003","unstructured":"Herbison P, Hay-Smith J, Ellis G, Moore K (2003) Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review. BMJ 326(7394):841\u2013844. doi: 10.1136\/bmj.326.7394.841326\/7394\/841","journal-title":"BMJ"},{"issue":"3","key":"736_CR5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.eururo.2010.11.021","volume":"59","author":"JW Thuroff","year":"2011","unstructured":"Thuroff JW, Abrams P, Andersson KE, Artibani W, Chapple CR, Drake MJ, Hampel C, Neisius A, Schroder A, Tubaro A (2011) EAU guidelines on urinary incontinence. Eur Urol 59(3):387\u2013400. doi: 10.1016\/j.eururo.2010.11.021","journal-title":"Eur Urol"},{"issue":"2","key":"736_CR6","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1590\/S1677-55382007000200002","volume":"33","author":"DE Rapp","year":"2007","unstructured":"Rapp DE, Lucioni A, Bales GT (2007) Botulinum toxin injection: a review of injection principles and protocols. Int Braz J Urol 33(2):132\u2013141","journal-title":"Int Braz J Urol"},{"issue":"9","key":"736_CR7","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/j.1464-410X.2009.08600.x","volume":"104","author":"J Pannek","year":"2009","unstructured":"Pannek J, Gocking K, Bersch U (2009) Long-term effects of repeated intradetrusor botulinum neurotoxin A injections on detrusor function in patients with neurogenic bladder dysfunction. BJU Int 104(9):1246\u20131250. doi: 10.1111\/j.1464-410X.2009.08600.x","journal-title":"BJU Int"},{"issue":"1","key":"736_CR8","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.ju.0000162035.73977.1c","volume":"174","author":"B Schurch","year":"2005","unstructured":"Schurch B, de Seze M, Denys P, Chartier-Kastler E, Haab F, Everaert K, Plante P, Perrouin-Verbe B, Kumar C, Fraczek S, Brin MF (2005) Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol 174(1):196\u2013200. doi: 10.1097\/01.ju.0000162035.73977.1c","journal-title":"J Urol"},{"key":"736_CR9","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/(SICI)1520-6777(1999)18:2<139::AID-NAU9>3.0.CO;2-U","volume":"18","author":"M Stohrer","year":"1999","unstructured":"Stohrer M, Schurch B, Kramer G, Schmid D, Gaul D, Hauri D (1999) Botulinum toxin A in the treatment of detrusor hyperreflexia in spinal cord injured patients: a new alternative to medical and surgical procedures? Neurourol Urodyn 18:401\u2013402","journal-title":"Neurourol Urodyn"},{"issue":"9","key":"736_CR10","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1056\/NEJM200003023420918","volume":"342","author":"B Schurch","year":"2000","unstructured":"Schurch B, Schmid DM, Stohrer M (2000) Treatment of neurogenic incontinence with botulinum toxin A. N Engl J Med 342(9):665","journal-title":"N Engl J Med"},{"issue":"1","key":"736_CR11","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000463995","volume":"17","author":"S Alloussi","year":"1990","unstructured":"Alloussi S, Loew F, Mast GJ, Jung P, Schwertfeger K, Steffens J, Ziegler M (1990) Value of selective reversible sacral nerve blockade in the diagnosis and treatment of the urge syndrome. Eur Urol 17(1):30\u201334","journal-title":"Eur Urol"},{"issue":"5","key":"736_CR12","first-page":"464","volume":"56","author":"S Alloussi","year":"1984","unstructured":"Alloussi S, Loew F, Mast GJ, Alzin H, Wolf D (1984) Treatment of detrusor instability of the urinary bladder by selective sacral blockade. Br J Urol 56(5):464\u2013467","journal-title":"Br J Urol"},{"issue":"1","key":"736_CR13","first-page":"39","volume":"23","author":"S Alloussi","year":"1984","unstructured":"Alloussi S, Loew F, Mast GJ, Wolf D (1984) Selective sacral nerve blockade in the treatment of detrusor hyperreflexia of the bladder. Urologe A 23(1):39\u201345","journal-title":"Urologe A"},{"key":"736_CR14","first-page":"CD005493","volume":"3","author":"J Duthie","year":"2007","unstructured":"Duthie J, Wilson DI, Herbison GP, Wilson D (2007) Botulinum toxin injections for adults with overactive bladder syndrome. Cochrane Database Syst Rev 3:CD005493. doi: 10.1002\/14651858.CD005493.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"736_CR15","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.eururo.2004.11.009","volume":"47","author":"J Grosse","year":"2005","unstructured":"Grosse J, Kramer G, Stohrer M (2005) Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence. Eur Urol 47(5):653\u2013659. doi: 10.1016\/j.eururo.2004.11.009","journal-title":"Eur Urol"},{"issue":"5","key":"736_CR16","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/j.1464-410X.2006.06091.x","volume":"97","author":"A Ruffion","year":"2006","unstructured":"Ruffion A, Capelle O, Paparel P, Leriche B, Leriche A, Grise P (2006) What is the optimum dose of type A botulinum toxin for treating neurogenic bladder overactivity? BJU Int 97(5):1030\u20131034. doi: 10.1111\/j.1464-410X.2006.06091.x","journal-title":"BJU Int"},{"issue":"6","key":"736_CR17","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.juro.2007.01.130","volume":"177","author":"A Sahai","year":"2007","unstructured":"Sahai A, Khan MS, Dasgupta P (2007) Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial. J Urol 177(6):2231\u20132236. doi: 10.1016\/j.juro.2007.01.130","journal-title":"J Urol"},{"issue":"1","key":"736_CR18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-5347(06)00590-8","volume":"176","author":"DM Schmid","year":"2006","unstructured":"Schmid DM, Sauermann P, Werner M, Schuessler B, Blick N, Muentener M, Strebel RT, Perucchini D, Scheiner D, Schaer G, John H, Reitz A, Hauri D, Schurch B (2006) Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics. J Urol 176(1):177\u2013185. doi: 10.1016\/S0022-5347(06)00590-8","journal-title":"J Urol"},{"issue":"2","key":"736_CR19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.eururo.2007.10.013","volume":"53","author":"G Karsenty","year":"2008","unstructured":"Karsenty G, Denys P, Amarenco G, De Seze M, Game X, Haab F, Kerdraon J, Perrouin-Verbe B, Ruffion A, Saussine C, Soler JM, Schurch B, Chartier-Kastler E (2008) Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity\/neurogenic overactive bladder: a systematic literature review. Eur Urol 53(2):275\u2013287. doi: 10.1016\/j.eururo.2007.10.013","journal-title":"Eur Urol"},{"issue":"3","key":"736_CR20","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.juro.2006.10.047","volume":"177","author":"G Karsenty","year":"2007","unstructured":"Karsenty G, Elzayat E, Delapparent T, St-Denis B, Lemieux MC, Corcos J (2007) Botulinum toxin type A injections into the trigone to treat idiopathic overactive bladder do not induce vesicoureteral reflux. J Urol 177(3):1011\u20131014. doi: 10.1016\/j.juro.2006.10.047","journal-title":"J Urol"},{"issue":"4","key":"736_CR21","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/nau.20403","volume":"26","author":"IF Ghalayini","year":"2007","unstructured":"Ghalayini IF, Al-Ghazo MA (2007) Intradetrusor injection of botulinum-A toxin in patients with idiopathic and neurogenic detrusor overactivity: urodynamic outcome and patient satisfaction. Neurourol Urodyn 26(4):531\u2013536. doi: 10.1002\/nau.20403","journal-title":"Neurourol Urodyn"},{"issue":"6","key":"736_CR22","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/j.1464-410X.2007.07186.x","volume":"100","author":"S Jeffery","year":"2007","unstructured":"Jeffery S, Fynes M, Lee F, Wang K, Williams L, Morley R (2007) Efficacy and complications of intradetrusor injection with botulinum toxin A in patients with refractory idiopathic detrusor overactivity. BJU Int 100(6):1302\u20131306. doi: 10.1111\/j.1464-410X.2007.07186.x","journal-title":"BJU Int"},{"issue":"9","key":"736_CR23","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.rehab.2009.07.032","volume":"52","author":"I Ksibi","year":"2009","unstructured":"Ksibi I, Godard AL, Azouvi P, Denys P, Dziri C (2009) Botulinum toxin and refractory non-neurogenic overactive detrusor. Ann Phys Rehabil Med 52(9):668\u2013683. doi: 10.1016\/j.rehab.2009.07.032","journal-title":"Ann Phys Rehabil Med"},{"issue":"5","key":"736_CR24","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.eururo.2007.09.034","volume":"53","author":"G Del Popolo","year":"2008","unstructured":"Del Popolo G, Filocamo MT, Li Marzi V, Macchiarella A, Cecconi F, Lombardi G, Nicita G (2008) Neurogenic detrusor overactivity treated with English botulinum toxin A: 8-year experience of one single centre. Eur Urol 53(5):1013\u20131019. doi: 10.1016\/j.eururo.2007.09.034","journal-title":"Eur Urol"},{"issue":"3","key":"736_CR25","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.eururo.2008.08.048","volume":"55","author":"A Giannantoni","year":"2009","unstructured":"Giannantoni A, Mearini E, Del Zingaro M, Porena M (2009) Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results. Eur Urol 55(3):705\u2013711. doi: 10.1016\/j.eururo.2008.08.048","journal-title":"Eur Urol"},{"issue":"4","key":"736_CR26","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.eururo.2003.12.004","volume":"45","author":"A Reitz","year":"2004","unstructured":"Reitz A, Stohrer M, Kramer G, Del Popolo G, Chartier-Kastler E, Pannek J, Burgdorfer H, Gocking K, Madersbacher H, Schumacher S, Richter R, von Tobel J, Schurch B (2004) European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol 45(4):510\u2013515. doi: 10.1016\/j.eururo.2003.12.004","journal-title":"Eur Urol"},{"key":"736_CR27","doi-asserted-by":"crossref","unstructured":"Wefer B, Ehlken B, Bremer J, Burgdorfer H, Domurath B, Hampel C, Kutzenberger J, Seif C, Sievert KD, Berger K, Pannek J (2009) Treatment outcomes and resource use of patients with neurogenic detrusor overactivity receiving botulinum toxin A (BOTOX(R)) therapy in Germany. World J Urol 28(3):385\u2013390. doi: 10.1007\/s00345-009-0466-1","DOI":"10.1007\/s00345-009-0466-1"},{"issue":"4","key":"736_CR28","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.eururo.2006.07.022","volume":"50","author":"AK Patel","year":"2006","unstructured":"Patel AK, Patterson JM, Chapple CR (2006) Botulinum toxin injections for neurogenic and idiopathic detrusor overactivity: a critical analysis of results. Eur Urol 50(4):684\u2013709. doi: 10.1016\/j.eururo.2006.07.022","journal-title":"Eur Urol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-011-0736-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-011-0736-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-011-0736-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T06:47:52Z","timestamp":1592808472000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-011-0736-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,13]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["736"],"URL":"https:\/\/doi.org\/10.1007\/s00345-011-0736-6","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,13]]}}}